| Allosteric modulators of HSP90 and HSP70: dynamics meets function through structure-based drug design M Ferraro, I D’Annessa, E Moroni, G Morra, A Paladino, S Rinaldi, ... Journal of medicinal chemistry 62 (1), 60-87, 2018 | 93 | 2018 |
| Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations G Chillemi, I D’Annessa, P Fiorani, C Losasso, P Benedetti, A Desideri Nucleic Acids Research 36 (17), 5645-5651, 2008 | 61 | 2008 |
| Interaction between natural compounds and human topoisomerase I S Castelli, A Coletta, I D’Annessa, P Fiorani, C Tesauro, A Desideri Biological Chemistry 393 (11), 1327-1340, 2012 | 59 | 2012 |
| Erybraedin C, a natural compound from the plant Bituminaria bituminosa, inhibits both the cleavage and religation activities of human topoisomerase I C Tesauro, P Fiorani, I d'Annessa, G Chillemi, G Turchi, A Desideri Biochemical Journal 425 (3), 531-539, 2010 | 55 | 2010 |
| Bioinformatics and biosimulations as toolbox for peptides and peptidomimetics design: where are we? I D’Annessa, FS Di Leva, A La Teana, E Novellino, V Limongelli, ... Frontiers in Molecular Biosciences 7, 66, 2020 | 49 | 2020 |
| Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I–DNA complex G Mancini, I D'Annessa, A Coletta, N Sanna, G Chillemi, A Desideri PloS one 5 (6), e10934, 2010 | 49 | 2010 |
| Ligand binding, unbinding, and allosteric effects: deciphering small-molecule modulation of HSP90 I D’Annessa, S Raniolo, V Limongelli, D Di Marino, G Colombo Journal of chemical theory and computation 15 (11), 6368-6381, 2019 | 46 | 2019 |
| Computational analysis of dengue virus envelope protein (E) reveals an epitope with flavivirus immunodiagnostic potential in peptide microarrays G Bergamaschi, EMA Fassi, A Romanato, I D’Annessa, MT Odinolfi, ... International journal of molecular sciences 20 (8), 1921, 2019 | 45 | 2019 |
| Design of allosteric stimulators of the Hsp90 ATPase as new anticancer leads I D'Annessa, S Sattin, J Tao, M Pennati, C Sŕnchez‐Martěn, E Moroni, ... Chemistry–A European Journal 23 (22), 5188-5192, 2017 | 42 | 2017 |
| Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant P Fiorani, C Tesauro, G Mancini, G Chillemi, I D'A; nnessa, G Graziani, ... Nucleic acids research 37 (20), 6849-6858, 2009 | 37 | 2009 |
| Structural dynamics of the mitochondrial ADP/ATP carrier revealed by molecular dynamics simulation studies M Falconi, G Chillemi, D Di Marino, I D'Annessa, B Morozzo della Rocca, ... Proteins: Structure, Function, and Bioinformatics 65 (3), 681-691, 2006 | 35 | 2006 |
| Simulations of DNA topoisomerase 1B bound to supercoiled DNA reveal changes in the flexibility pattern of the enzyme and a secondary protein–DNA binding site I D'Annessa, A Coletta, T Sutthibutpong, J Mitchell, G Chillemi, S Harris, ... Nucleic acids research 42 (14), 9304-9312, 2014 | 34 | 2014 |
| Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico C Tesauro, B Morozzo della Rocca, A Ottaviani, A Coletta, L Zuccaro, ... Molecular cancer 12, 1-13, 2013 | 34 | 2013 |
| Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-CoV-2 spike variant E Trucchi, P Gratton, F Mafessoni, S Motta, F Cicconardi, F Mancia, ... Molecular biology and evolution 38 (5), 1966-1979, 2021 | 33* | 2021 |
| Structural-dynamical properties of the Deinococcus radiodurans topoisomerase IB in absence of DNA: correlation with the human enzyme. D Ilda, C Giovanni, D Alessandro Journal of biomolecular structure & dynamics 27 (3), 307, 2009 | 32 | 2009 |
| A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance C Losasso, E Cretaio, P Fiorani, I D’Annessa, G Chillemi, P Benedetti Nucleic acids research 36 (17), 5635-5644, 2008 | 31 | 2008 |
| Handling FMRP and its molecular partners: Structural insights into Fragile X Syndrome I D'Annessa, F Cicconardi, D Di Marino Progress in biophysics and molecular biology 141, 3-14, 2019 | 30 | 2019 |
| Enhancing antibody serodiagnosis using a controlled peptide coimmobilization strategy L Sola, P Gagni, I D’Annessa, R Capelli, C Bertino, A Romanato, F Damin, ... ACS infectious diseases 4 (6), 998-1006, 2018 | 30 | 2018 |
| A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors D Di Marino, I D'Annessa, H Tancredi, C Bagni, E Gallicchio Protein Science 24 (9), 1370-1382, 2015 | 30 | 2015 |
| A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision … A Gandaglia, E Brivio, S Carli, M Palmieri, F Bedogni, G Stefanelli, ... Molecular neurobiology 56, 4838-4854, 2019 | 29 | 2019 |
